Study Comparing Cyclosporin Dose Reduction With Cyclosporin Elimination in Kidney Transplant Recipients Taking Sirolimus
Status:
Completed
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
To assess equivalence in the rates of functional graft survival at 12 months after
transplantation in patients receiving induction therapy with cyclosporin (CsA, Neoral) and
Rapamune® followed by CsA dose reduction and concentration-controlled Rapamune® versus
induction with CsA and Rapamune® followed by discontinuation of CsA and
concentration-controlled Rapamune®.